Visual outcome following chemotherapy for progressive optic pathway gliomas.
about
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.Impact of vision loss among survivors of childhood central nervous system astroglial tumors.Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.Functional outcome measures for NF1-associated optic pathway glioma clinical trials.Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN/PI3K-regulated glioma transcriptional signature.Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity.Long-term outcome of centrally located low-grade glioma in children.Visual acuity of children treated with chemotherapy for optic pathway gliomas.
P2860
Q36010097-0BA6394A-4BFB-4D01-A743-6EE479FBCBC2Q36609635-71D78F57-9D67-4993-B3AB-498C3F055D7FQ36771546-9379079D-AED3-4B27-BD31-DB26C9F29905Q36968257-95404A1A-2193-4E1E-8105-75F1282C3868Q37021573-AE984B8D-1BBB-4853-8B96-3F06C991C976Q37536287-098E3780-D9BB-4579-863C-2B031A36B18DQ40976967-D7FF2750-4C9E-48D1-8039-E6E1DF2A8695Q41096365-3818C175-6943-408F-839C-19B0602409EDQ41592763-5F02DCBD-53CC-4CCB-8E79-B1A200910679Q46667195-15409642-FA3D-4DA2-A9AB-8B0E77391C14Q46836518-E37EE191-892E-43FD-8ABA-52983DE645C9Q48711567-12E38133-9C12-4FFA-86A7-BE70EFFE24BEQ50419922-DD53F842-BFE7-4D6A-89E4-AA0CB2FBFC69Q51033876-288DD5A4-AD56-4F30-A779-C29D614070C1Q55461513-036CFC68-2D68-4219-9A50-C6D5C9E9F389
P2860
Visual outcome following chemotherapy for progressive optic pathway gliomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@en
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@nl
type
label
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@en
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@nl
prefLabel
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@en
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@nl
P2093
P2860
P356
P1476
Visual outcome following chemotherapy for progressive optic pathway gliomas.
@en
P2093
Anat Kesler
Ben Shofty
Hagit Toledano
Liat Ben-Sira
Michael Weintraub
Michal Yalon
Shlomi Constantini
Sigal Freedman
P2860
P304
P356
10.1002/PBC.22967
P577
2011-01-16T00:00:00Z